Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Business Update

Novartis India Business Update

Novartis India terminated its 2022 distribution agreement with Dr. Reddy's Laboratories, effective September 30, 2026. The company will now re-acquire exclusive product distribution and marketing rights.

Source

BSE filing, NSE: NOVARTIND. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Novartis India Ltd: key numbers

Share price
₹1,805.95
Market cap
₹4,459 Cr
Revenue (annual)
₹354.3 Cr
Net profit (annual)
₹93.18 Cr
P/E (TTM)
45.6×Sector 46.1×
Promoter holding
70.68%+0.00% QoQ
FII holding
1.21%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Novartis India Ltd

All →
19:01 IST BSE
Fund Raise

Novartis India Fund Raise of ₹900 Cr

Evonile Pharma Limited approved a rights issue to raise up to ₹900 Crore. The company also formed a committee to manage the issuance terms.

Value
₹900.0 Cr

Other business update announcements

All →